Searched for
RUSSIAN DRUG MAKERS
Japan's Nikkei snaps 5-day losing streak amid US rate cautionThe Japanese government said on Wednesday the country would restart more idled nuclear plants and look at developing next-generation reacto...- Dr Reddy's net profit plunges 76% in Q4Sales from Russia at ₹686 crore was also 45% higher sequentially, the company said. The market contributed about 13% to Dr Reddy's sales in...
- Local drug companies in a fix over Sputnik amid sanctions against RDIFRDIF is commercialising the Sputnik vaccine globally, which was developed by Russia's Gamaleya Research Institute.
- Wockhardt, Enso Health join hands for Sputnik jabsDrug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...
- Made in India Sputnik V to be available during September- October: Dr Reddy'sDr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021 af...
- Hetero begins Sputnik V production at Hyderabad facilityIn an interaction with the Russian president Vladimir Putin on Friday through a video conference, Hetero group’s Chairman Dr Bandi Parthasa...
- Fortis to offer Sputnik V vaccineThe vaccine stock has been procured directly from Dr Reddy's Laboratories according to government guidelines, the private hospital chain sa...
- Dr Reddy's in talks with RDIF on Sputnik V for other countriesDr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for pilo...
- Shilpa Medicare arm inks pact with Dr Reddy's to manufacture Sputnik V vaccine"The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr...
- Second batch of Russia's COVID-19 vaccine Sputnik V reaches HyderabadDr Reddy's Laboratories on May 14 soft-launched imported COVID-19 vaccine Sputnik V vaccine which is priced at Rs948, with five per cent GS...
- Russia lags behind others in its COVID-19 vaccination driveRussia's lagging vaccination rates hinge on several factors, including supply. Russian drug makers have been slow to ramp up mass productio...
- Vaccine manufacturers frame plans to boost productionCompanies manufacturing vaccines are looking at a price of Rs 500 to Rs 1,000 per dose for the Indian private market, industry insiders tol...
- No approval for Sputnik V vaccine yet; Drug authority seeks additional data from Dr Reddy'sIn September 2020, Dr. Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of Sputnik V and...
- Dr Reddy's seeks emergency use authorization for Russia's Sputnik V vaccineThe Hyderabad-headquartered company, which had entered into a partnership with the Russian Direct Investment Fund (RDIF) last September to ...
- Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
- Sun Pharma to acquire 85 per cent stake in Russia's BiosintezBiosintez focuses on the hospital segment with annual revenues of about USD 52 million for 2015.
- Lupin acquires Russian drug firm BiocomThe acquisition marks Mumbai-based firm's entry into the Russian pharmaceutical market which recorded RUB 765 billion in sales.
- Cadila Pharmaceuticals looking to set up $150 million manufacturing unit in AstrakhanThe company is looking for an opportunity in Astrakhan to acquire land for setting up manufacturing unit in that country.
- Dr Reddy's Laboratories' sales may be hit as countries attempt to cut costsDRL today said it may see some pressure on revenues as governments around the globe attempt to cut healthcare costs.
- Natco to enter Russian, S American markets in 2 yearsGeneric drug maker Natco Pharma plans to enter the Russian and South American markets in the next two years.
Load More
